We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Breast Tumor Oxygen Status Revealed by Light

By LabMedica International staff writers
Posted on 29 Apr 2009
Light directed at a breast tumor through a needle can provide pathologists with biologic specifics of the tumor and help oncologists choose treatment options that would be most effective for that individual patient. More...


Duke University (Durham, NC, USA) bioengineers have developed a light-based system that can quickly and easily provide important information about oxygen levels within a tumor while it is still in place. The new system, based on diffuse reflectance spectroscopy, gives researchers significant insights about the tumor by interpreting how the light is either reflected back from the tumor or absorbed.

Oxygen status is important, according to the researchers, since past studies have shown that low levels of oxygen, or hypoxia, are more often associated with malignant tissue than healthy normal tissue. Tumors that thrive in these low-oxygen environments tend to be more difficult to treat, the researchers reported. "We developed an easy-to-use fiberoptic probe that can provide immediate and nondestructive measurements of tumor oxygenation," said Dr. J. Quincy Brown, a fourth-year postdoctoral fellow in the laboratory of Dr. Nirmala Ramanujam, associate professor of biomedical engineering at Duke's Pratt School of Engineering. The findings of the Duke experiments were published April 1, 2009, in the journal Cancer Research.

"This new approach could be an important new tool for physicians in determining the aggressiveness of a specific tumor and which therapies might work best against it," Dr. Brown said. "Since this system is compatible with commonly used biopsy needles, we could make oxygen measurements at the time of a needle biopsy, providing immediate feedback about the tumor's oxygen concentration."

In their current study, the researchers enrolled 35 women who were to undergo surgery for their breast cancer. Before the surgery, the researchers directed normal, ultraviolet- (UV)-visible light directly through a needle at the surface of the tumor while it was still in the breast. Since the system gathers data immediately, researchers are able to take readings at multiple locations in little time.

Their main target was blood and its hemoglobin, a protein, which is responsible for carrying oxygen throughout the body, as well as to tumors. While some types of breast cancer thrive in environments low in oxygen, other cancers stimulate the growth of new blood vessels to feed oxygen to the tumor. "Our system measured how the light was either absorbed by the hemoglobin, which gave us an optical fingerprint of the oxygen status of the tumor," Dr. Brown explained. "This fingerprint can give clues about which form of therapy--chemo, radiation, surgery--might be the most effective for that particular tumor."

An interesting finding involved tumors with the HER2/neu gene. It is estimated that one in five breast tumors exhibit overexpression of the HER2/neu gene. A commonly used drug known as Herceptin, which can block HER2/neu overexpression, is only effective in treating tumors with this gene.

"The tumors that overexpressed the HER2/neu gene had significantly higher levels of oxygen," Dr. Brown said. "This is likely due to the fact that the amplification of this gene encourages the formation of tiny new blood vessels, which in turn feed the tumor. Knowing how the Her2/neu status of a tumor is affecting tumor oxygenation at the time of biopsy would be useful information for the oncologist, since overexpression of this gene typically leads to a cancer that is more aggressive and more resistant to treatment."

The researchers are planning future studies of breast cancer patients undergoing chemotherapy by taking regular oxygen measurements to determine how a specific tumor is responding to therapy over time.

Related Links:

Duke University




New
Gold Member
Hematology Analyzer
Medonic M32B
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.